← Open Payments lookup

CHELSEA WHITE: Open Payments

NPI 1205470317 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,261 in 48 payments from 22 companies in 2025. Trend: 2023 $444 · 2024 $801 · 2025 $2,261

Food & beverage: $1,481Consulting: $780
CompanyPaymentsAmount
Genmab U.S., Inc.3$836
PFIZER INC.7$259
ABBVIE INC.8$150
Janssen Biotech, Inc.2$136
GENZYME CORPORATION1$126
Incyte Corporation1$125
AstraZeneca Pharmaceuticals LP4$105
Regeneron Healthcare Solutions, Inc.4$91
Novartis Pharmaceuticals Corporation2$57
Janssen Scientific Affairs, LLC1$55

Products named: Epkinly, ELREXFIO, SARCLISA, Monjuvi, RYBREVANT, TECVAYLI, LYNOZYFIC, IMFINZI.

Industry payments across TX — which companies pay providers there.